COMMUNIQUÉS West-GlobeNewswire

Trading in Novo Nordisk shares by board members, executives and associated persons on 9 August 2019
12/08/2019
Bagsværd, Denmark, 12 August 2019 — This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article [...]
INmune Bio Reports Second Quarter 2019 Financial Results and Provides Shareholder Update
12/08/2019
LA JOLLA, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ) (the “Company”), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight [...]
Gritstone Oncology Reports Second Quarter 2019 Financial Results and Recent Highlights
12/08/2019
EMERYVILLE, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]
City Cannabis Opens Two New Premier Cannabis Retail Locations in British Columbia
12/08/2019
VANCOUVER, British Columbia, Aug. 12, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “Company”) is excited to announce that BC’s Liquor and Cannabis Regulation Branch has [...]
CeCors, Inc. Announces New Value-Added Feature to RASCI’s Menu of Services for Healthcare Providers
12/08/2019
LAS VEGAS, NV, Aug. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CeCors, Inc. (OTC PINK: CEOS) , a Company focused on the Health & Technology Sector as well as other Emerging Technologies, is pleased to announce [...]
CV Sciences, Inc. CEO Issues Letter to Shareholders
12/08/2019
SAN DIEGO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products through its [...]
Guardion Health Sciences Reports June 30, 2019 Interim Results of Operations
12/08/2019
Highlights Include: 18.2% Revenue Growth for the Three Months Ended June 30, 2019 and 21.7% Revenue Growth for the Six Months Ended June 30, 2019 San Diego, CA , Aug. 12, 2019 (GLOBE NEWSWIRE) -- Guardion Health [...]
Tower One Development Update
12/08/2019
VANCOUVER, British Columbia, Aug. 12, 2019 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces it has received a progress update from its [...]
Yield10 Bioscience Announces Notice of Allowance for U.S. Patent Covering Crop Yield Trait C4001
12/08/2019
WOBURN, Mass., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Cassava Sciences Announces Second Quarter 2019 Financial Results
12/08/2019
AUSTIN, Texas, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biopharmaceutical company developing PTI-125 for Alzheimer’s disease, today reported financial results for the [...]
Qrons Announces Upgrade to OTCQB Market
12/08/2019
Trading Continues Under Ticker "QRON" NEW YORK, NY, Aug. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Qrons Inc. (OTCQB: QRON) an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based [...]
Blueberries Medical Announces $3 Million Non-Brokered Private Placement
12/08/2019
TORONTO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a leading Latin American licensed producer of medicinal cannabis and cannabis [...]
DiaMedica Therapeutics to Present at the 2019 Intellisight Investor Conference on August 14, 2019
12/08/2019
MINNEAPOLIS, Aug. 12, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that Rick Pauls, President and CEO, will be presenting at the 2019 Intellisight Conference, Wednesday, August 14 [...]
miRagen Therapeutics to Present a Corporate Overview at the 2019 Wedbush Healthcare Conference
12/08/2019
BOULDER, Colo., Aug. 12, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, [...]
TYME Announces Abstracts Selected for Presentation at the European Society of Medical Oncology Congress 2019
12/08/2019
SM-88 (racemetyrosine) is an oral, investigational cancer metabolism-based therapy that has demonstrated responses across 15 different cancers New oral approach aimed at disrupting cancer metabolism in metastatic [...]
Cyclerion Therapeutics Reports Second Quarter 2019 Financial Results and Progress on Four Clinical Studies with Data Readouts Anticipated in the Next 12 Months
12/08/2019
– Two praliciguat Phase 2 studies for diabetic nephropathy and heart failure with preserved ejection fraction (HFpEF) on track for data readouts in Q4 2019 – – Phase 2 study of olinciguat in sickle cell disease on track [...]
Tonix Pharmaceuticals Reports Second Quarter 2019 Financial Results and Operational Highlights
12/08/2019
Enrollment Continues for Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD; Topline Data Expected First Half of 2020 Pipeline Expanded in Addiction Medicine with Cocaine Antidote TNX-1300 and Potential New [...]
Mustang Bio to Present at 11th Annual Bioprocessing Summit
12/08/2019
NEW YORK, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Salarius Pharmaceuticals CEO Issues Letter to Stockholders
12/08/2019
HOUSTON, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of cancers, today announced that its chief executive officer, [...]

Pages